Cargando…

RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis

OBJECTIVE: Regulator of chromosome condensation 2 (RCC2) has been reported to be involved in the regulation of cell cleavage. This study investigated the effect of RCC2 expression on breast tumorigenesis. METHODS: MCF-7 cells originating from estrogen receptor-positive (ER+) breast cancer were trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Weiqi, Xu, Bing, Zhang, Zhaoxu, Fang, Kehua, Chang, Xiaotian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262660/ https://www.ncbi.nlm.nih.gov/pubmed/32565805 http://dx.doi.org/10.1155/2020/5619462

Ejemplares similares

The Multifaceted Roles of RCC1 in Tumorigenesis
por: Ren, Xuanqi, et al.
Publicado: (2020)

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis
por: Fang, Zhiyu, et al.
Publicado: (2021)

ARHGEF10L Promotes Cervical Tumorigenesis via RhoA-Mediated Signaling
por: Tang, Junyi, et al.
Publicado: (2021)

PRMT2 promotes RCC tumorigenesis and metastasis via enhancing WNT5A transcriptional expression
por: Li, Zhongwei, et al.
Publicado: (2023)

M1-Type Macrophages Secrete TNF-α to Stimulate Vascular Calcification by Upregulating CA1 and CA2 Expression in VSMCs
por: Song, Xianqin, et al.
Publicado: (2023)

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
por: Wrzesiński, Tomasz, et al.
Publicado: (2015)

PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability
por: Chen, Siming, et al.
Publicado: (2021)

AKTIP loss is enriched in ERα-positive breast cancer for tumorigenesis and confers endocrine resistance
por: Ng, Angel S.N., et al.
Publicado: (2022)

TOPK/PBK is phosphorylated by ERK2 at serine 32, promotes tumorigenesis and is involved in sorafenib resistance in RCC
por: Sun, Huimin, et al.
Publicado: (2022)

CircPVT1 promotes ER‐positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS
por: Yi, Jia, et al.
Publicado: (2023)

Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis
por: Zeng, Hao, et al.
Publicado: (2015)

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
por: Dhanasekaran, Renumathy, et al.
Publicado: (2020)

PADI4 and tumourigenesis
por: Chang, Xiaotian, et al.
Publicado: (2010)

2-Deoxy-D-glucose Alleviates Collagen-Induced Arthritis of Rats and Is Accompanied by Metabolic Regulation of the Spleen and Liver
por: Wang, Hongxing, et al.
Publicado: (2021)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC
por: Gu, Junfei, et al.
Publicado: (2020)

Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody
por: Wang, Yan, et al.
Publicado: (2023)

Uridine Diphosphate Promotes Rheumatoid Arthritis Through P2Y6 Activation
por: Wang, Hongxing, et al.
Publicado: (2021)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Pivotal biomarker expression and drug screening in advanced ccRCC
por: Xiao, Wen, et al.
Publicado: (2020)

Co-Expression of Multiple PAX Genes in Renal Cell Carcinoma (RCC) and Correlation of High PAX Expression with Favorable Clinical Outcome in RCC Patients
por: Li, Lei, et al.
Publicado: (2023)

Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data
por: Kajdasz, Arkadiusz, et al.
Publicado: (2021)

A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC
por: Piao, Xuan-Mei, et al.
Publicado: (2023)

Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy
por: Kim, Tae-Jung, et al.
Publicado: (2012)

TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression
por: Xie, Lingling, et al.
Publicado: (2023)

AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer
por: Zhou, Meng, et al.
Publicado: (2023)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Open Surgery for Localized RCC
por: Vander Eeckt, Kathy, et al.
Publicado: (2007)

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
por: Pinhel, Isabel, et al.
Publicado: (2012)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression
por: Zhang, Zhongfa, et al.
Publicado: (2010)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis
por: Romagnolo, Donato F., et al.
Publicado: (2015)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Porras, Lucas, et al.
Publicado: (2021)

RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT
por: Chen, Zhen, et al.
Publicado: (2019)

Expression and Role of Epithelial Membrane Proteins in Tumorigenesis of Hormone Receptor-Positive Breast Cancer
por: Cha, Yoon Jin, et al.
Publicado: (2020)

Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E(2)-dependent growth of ER-positive breast cancer
por: Ka, Na-Lee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3eu6lu0lrpmuij7q88e6tokgs